StockData

Exozymes Inc. (EXOZ) stock

EXOZNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30
$2.90−0.48 (-14.05%)

Close on Nov 20, 2026Market cap $26.96MP/E –Yield –

Exozymes gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Exozymes

Exozymes has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Exozymes figures

See a number that looks wrong?